HANSAMED INC FDA Approval ANDA 201750

ANDA 201750

HANSAMED INC

FDA Drug Application

Application #201750

Application Sponsors

ANDA 201750HANSAMED INC

Marketing Status

Discontinued001

Application Products

001INJECTABLE;INJECTION4%;EQ 0.017MG BASE/1.7ML (4%; EQ 0.01MG BASE/ML)0ULTACAN FORTEARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE

FDA Submissions

ORIG1AP2017-07-11

Submissions Property Types

ORIG1Null7

CDER Filings

HANSAMED INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 201750
            [companyName] => HANSAMED INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"ULTACAN FORTE","activeIngredients":"ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE","strength":"4%;EQ 0.017MG BASE\/1.7ML (4%; EQ 0.01MG BASE\/ML)","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"07\/11\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2017-07-11
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.